TetraKit Technologies - Updated website

We’re pleased to share that our website has been updated!

Visit tetrakit.com to learn about our growing pipeline and how the TetraKit Platform turns cancer-targeting biomolecules into radiopharmaceuticals labeled with astatine-211 and other radionuclides ☢️

February 2, 2026

We are excited to welcome Darja Beyer to our team!

Darja will be joining us as a Senor Translational Scientist and will play a key role in advancing translational radiopharmaceutical research☢️ A warm welcome to our newest team member, Darja! She … Read more

January 30, 2026

Accelerate.EU consortium at TWC

Great to be at the Theranostics World Congress with the Accelerate.EU consortium.We are happy to share the progress made on Astatine-211 and targeted alpha therapies, and to highlight Antero Abrunhosa… Read more

January 22, 2026

Just one week to go! 🔬

The 8th Theranostics World Congress is just around the corner and we’re very excited to attend. During the congress, our CEO and Co-founder, Dr. Matthias Herth, will present a talk on halogenated FA… Read more

Updated website

Connect with us: